Christopher P. Austin

Research.com Recognitions

• 2015 - Member of the National Academy of Medicine (NAM)
• Member of the Association of American Physicians
• Member of the Association of American Physicians
• Member of the Association of American Physicians

Overview

Best Publications

• A call for transparent reporting to optimize the predictive value of preclinical research

  Story C. Landis;Susan G. Amara;Khusru Asadullah;Chris P. Austin

  1228
  Citations

• Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries.

  James Inglese;Douglas S. Auld;Ajit Jadhav;Ronald L. Johnson

  883
  Citations

• Identification of the gene responsible for Best macular dystrophy

  K. Petrukhin;M. J. Koisti;B. Bakall;Wen Li

  799
  Citations

• Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.

  Dimitrios Anastasiou;Yimin Yu;William James Israelsen;Jian-Kang Jiang

  785
  Citations

• The knockout mouse project

  Christopher P. Austin;James F. Battey;Allan Bradley;Maja Bucan

  764
  Citations

• High-throughput screening assays for the identification of chemical probes

  James Inglese;Ronald L Johnson;Anton Simeonov;Menghang Xia

  727
  Citations

• Organs-on-chips: into the next decade

  Lucie A. Low;Christine Mummery;Christine Mummery;Brian R. Berridge;Christopher P. Austin

  643
  Citations

• Improving the Human Hazard Characterization of Chemicals: A Tox21 Update

  Raymond R. Tice;Christopher P. Austin;Robert J. Kavlock;John R. Bucher

  590
  Citations

• The National COVID Cohort Collaborative (N3C): Rationale, Design, Infrastructure, and Deployment.

  Melissa A Haendel;Melissa A Haendel;Christopher G Chute;Tellen D Bennett;David A Eichmann

  564
  Citations

• A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy

  Kang Zhang;Kang Zhang;Marina Kniazeva;Min Han;Wen Li

  500
  Citations

• The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics

  Ruili Huang;Noel Southall;Yuhong Wang;Adam Yasgar

  440
  Citations

• High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells

  Lesley A. Mathews Griner;Rajarshi Guha;Paul Shinn;Ryan M. Young

  427
  Citations

• A high-throughput screen for aggregation-based inhibition in a large compound library.

  Brian Y. Feng;Anton Simeonov;Ajit Jadhav;Kerim Babaoglu

  408
  Citations

• NIH Molecular Libraries Initiative.

  Christopher P. Austin;Linda S. Brady;Thomas R. Insel;Francis S. Collins

  391
  Citations

• A role for the melanocortin 4 receptor in sexual function.

  Lex H. T. Van der Ploeg;William J. Martin;Andrew D. Howard;Ravi P. Nargund

  376
  Citations

• Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression.

  Carina P. Tan;Hideki Sano;Hisashi Iwaasa;Jie Pan

  320
  Citations

• Identification of Known Drugs that Act as Inhibitors of NF-κB Signaling and their Mechanism of Action

  Susanne C. Miller;Ruili Huang;Srilatha Sakamuru;Sunita J. Shukla

  313
  Citations

• Identification of oxadiazoles as new drug leads for the control of schistosomiasis

  Ahmed A Sayed;Anton Simeonov;Craig J Thomas;James Inglese

  312
  Citations

• Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R

  Andreas W. Sailer;Hideki Sano;Zhizhen Zeng;Terrence P. McDonald

  309
  Citations

• The future of toxicity testing: a focus on in vitro methods using a quantitative high-throughput screening platform

  Sunita J. Shukla;Ruili Huang;Christopher P. Austin;Menghang Xia

  308
  Citations